Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multi-Center, Safety and Pharmacokinetic Bridging Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring in Normal and Renal Compromised Subjects for the Evaluation of Kidney Function

NCT05777174 is registered in ClinicalTrials.gov with MediBeacon as lead sponsor.

NCT NCT05777174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05777174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multi-Center, Safety and Pharmacokinetic Bridging Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring in Normal and Renal Compromised Subjects for the Evaluation of Kidney Function
Lead sponsor
MediBeacon
Phase
Phase 3
Overall status
Completed
Start date
March 20, 2023
Completion date
April 15, 2024
Enrollment
149 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

kidney diseases, kidney failure, kidney injury